相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of prasugrel and clopidogrel in patients with non-cardioernbolic ischaernic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I) (vol 18, pg 238, 2019)
A. Ogawa et al.
LANCET NEUROLOGY (2020)
Blood pressure variability in subacute stage and risk of major vascular events in ischemic stroke survivors
Jihoon Kang et al.
JOURNAL OF HYPERTENSION (2019)
Effect of Standard vs Intensive Blood Pressure Control on the Risk of Recurrent Stroke A Randomized Clinical Trial and Meta-analysis
Kazuo Kitagawa et al.
JAMA NEUROLOGY (2019)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura et al.
HYPERTENSION RESEARCH (2019)
Blood Pressure Variability and Cardiovascular Outcomes in Patients With Prior Stroke A Secondary Analysis of PRoFESS
Adam de Havenon et al.
STROKE (2019)
Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis
Maurizio Paciaroni et al.
CARDIOVASCULAR THERAPEUTICS (2019)
Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)
Akira Ogawa et al.
LANCET NEUROLOGY (2019)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NM CNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Paul K. Whelton et al.
HYPERTENSION (2018)
A noninferiority confirmatory trial of prasugrel versus clopidogrel in Japanese patients with non-cardioembolic stroke: rationale and study design for a randomized controlled trial - PRASTRO-I trial
Takehiko Nagao et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
The risk of bleeding with the use of antiplatelet agents for the treatment of cardiovascular disease
Ashwin S. Nathan et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Intensive versus Guideline Blood Pressure and Lipid Lowering in Patients with Previous Stroke: Main Results from the Pilot 'Prevention of Decline in Cognition after Stroke Trial' (PODCAST) Randomised Controlled Trial
Philip M. Bath et al.
PLOS ONE (2017)
Risk of bleeding and repeated bleeding events in prasugrel-treated patients: a review of data from the Japanese PRASFIT studies
Masakatsu Nishikawa et al.
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS (2017)
Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial
Jonathan Mant et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial
Jonathan Mant et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis
Liang Tan et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Efficacy and Safety of Cilostazol Therapy in Ischemic Stroke: A Meta-analysis
Liang Tan et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Benefit of Cilostazol in Patients with High Risk of Bleeding: Subanalysis of Cilostazol Stroke Prevention Study 2
Shinichiro Uchiyama et al.
CEREBROVASCULAR DISEASES (2014)
Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome - The PRASFIT-ACS Study
Shigeru Saito et al.
CIRCULATION JOURNAL (2014)
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial
O. R. Benavente et al.
LANCET (2013)
Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel The Importance of CYP2C19*2 Genotyping
Dimitrios Alexopoulos et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke
Bruce Ovbiagele et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
CEREBRAL INFARCTION/TRANSIENT ISCHEMIC ATTACK (TIA)
Yukito Shinohara et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2011)
Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial
Hisatomi Arima et al.
STROKE (2011)
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
Peter M. Rothwell et al.
LANCET (2010)
Blood Pressure Levels and Bleeding Events During Antithrombotic Therapy The Bleeding With Antithrombotic Therapy (BAT) Study
Kazunori Toyoda et al.
STROKE (2010)
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes
Jessica L. Mega et al.
CIRCULATION (2009)
Pharmacotherapy for the Secondary Prevention of Stroke
Kazunori Toyoda
DRUGS (2009)
Impact of blood pressure levels on different types of stroke: the Hisayama study
Hisatomi Arima et al.
JOURNAL OF HYPERTENSION (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial
Hisatomi Arima et al.
JOURNAL OF HYPERTENSION (2006)
分享论文
